期刊文献+
共找到109篇文章
< 1 2 6 >
每页显示 20 50 100
microRNA-455-5p alleviates neuroinflammation in cerebral ischemia/reperfusion injury 被引量:3
1
作者 Jian-Song Zhang Pin-Pin Hou +8 位作者 Shuai Shao Anatol Manaenko Zhi-Peng Xiao Yan Chen Bing Zhao Feng Jia Xiao-Hua Zhang Qi-Yong Mei Qin Hu 《Neural Regeneration Research》 SCIE CAS CSCD 2022年第8期1769-1775,共7页
Neuroinflammation is a major pathophysiological factor that results in the development of brain injury after cerebral ischemia/reperfusion.Downregulation of microRNA(miR)-455-5p after ischemic stroke has been consider... Neuroinflammation is a major pathophysiological factor that results in the development of brain injury after cerebral ischemia/reperfusion.Downregulation of microRNA(miR)-455-5p after ischemic stroke has been considered a potential biomarker and therapeutic target for neuronal injury after ischemia.However,the role of miR-455-5p in the post-ischemia/reperfusion inflammatory response and the underlying mechanism have not been evaluated.In this study,mouse models of cerebral ischemia/reperfusion injury were established by transient occlusion of the middle cerebral artery for 1 hour followed by reperfusion.Agomir-455-5p,antagomir-455-5p,and their negative controls were injected intracerebroventricularly 2 hours before or 0 and 1 hour after middle cerebral artery occlusion(MCAO).The results showed that cerebral ischemia/reperfusion decreased miR-455-5p expression in the brain tissue and the peripheral blood.Agomir-455-5p pretreatment increased miR-455-5p expression in the brain tissue,reduced the cerebral infarct volume,and improved neurological function.Furthermore,primary cultured microglia were exposed to oxygen-glucose deprivation for 3 hours followed by 21 hours of reoxygenation to mimic cerebral ischemia/reperfusion.miR-455-5p reduced C-C chemokine receptor type 5 mRNA and protein levels,inhibited microglia activation,and reduced the production of the inflammatory factors tumor necrosis factor-αand interleukin-1β.These results suggest that miR-455-5p is a potential biomarker and therapeutic target for the treatment of cerebral ischemia/reperfusion injury and that it alleviates cerebral ischemia/reperfusion injury by inhibiting C-C chemokine receptor type 5 expression and reducing the neuroinflammatory response. 展开更多
关键词 agomiR-455-5p biomarker blood-brain barrier C-C chemokine receptor type 5 ischemia/reperfusion injury ischemic stroke MICROGLIA microrna-455-5p NEUROINFLAMMATION pRETREATMENT
下载PDF
胃饥饿素通过miR-455-5p靶向IGF-1R调控肝细胞胰岛素敏感性的作用及机制研究
2
作者 郭展宏 居悦俊 +4 位作者 沈婷 张琳琪 盛忠奇 吴润泽 孔颖宏 《海南医学院学报》 北大核心 2024年第1期21-28,共8页
目的:探究胃饥饿素通过调控miR-455-5p影响肝细胞胰岛素敏感性的作用机制。方法:采用高糖构建HepG2细胞胰岛素抵抗模型,造模成功后使用去酰基化胃饥饿素(DAG,1μmol/L)干预,分别转染miR-455-5p模拟物(miR-455-5p mimic)或对照物(NC mim... 目的:探究胃饥饿素通过调控miR-455-5p影响肝细胞胰岛素敏感性的作用机制。方法:采用高糖构建HepG2细胞胰岛素抵抗模型,造模成功后使用去酰基化胃饥饿素(DAG,1μmol/L)干预,分别转染miR-455-5p模拟物(miR-455-5p mimic)或对照物(NC mimic)。检测各组细胞葡萄糖消耗量和细胞内糖原含量。采用荧光原位杂交分析HepG2细胞内miR-455-5p表达水平。应用生物信息学分析、荧光素酶报告基因实验来鉴定与miR-455-5p结合的靶基因,Western Blot检测IGF-1R/PI3K/Akt信号通路的表达水平。结果:在胰岛素抵抗HepG2细胞中,miR-455-5p的表达水平显著上调,葡萄糖消耗量和细胞内糖原含量均明显降低。DAG干预后细胞葡萄糖消耗量和细胞内糖原含量增加,miR-455-5p的表达水平下调,IGF-1R/PI3K/Akt信号通路被激活。生物信息学分析表明IGF-1R是miR-455-5p的靶基因。双荧光素酶报告基因检测、miR-455-5p模拟物和抑制剂转染证实DAG通过抑制miR-455-5p从而激活IGF-1R/PI3K/Akt信号通路。结论:DAG通过miR-455-5p介导的IGF-1R/PI3K/Akt信号通路激活并改善胰岛素抵抗,表明抑制miR-455-5p或外源性补充DAG可能是T2DM治疗的潜在靶点。 展开更多
关键词 胃饥饿素 miR-455-5p IGF-1R 胰岛素抵抗 HEpG2细胞
下载PDF
MicroRNA-363-5p靶向血小板反应蛋白-3调控心肌细胞肥大的作用机制研究
3
作者 马玉坤 单正宜 +2 位作者 刘荟婷 昝树槐 赵鹏 《中国现代医学杂志》 CAS 2024年第12期24-32,共9页
目的 探讨microRNA-363-5p(miR-363-5p)靶向血小板反应蛋白-3(THBS3)对心肌肥大的调节作用。方法 体外人心肌细胞(AC16)经血管紧张素Ⅱ(AngⅡ)处理复制心肌肥大体外模型,随后鬼笔环肽染色观察细胞骨架,Western blotting检测心肌肥大体... 目的 探讨microRNA-363-5p(miR-363-5p)靶向血小板反应蛋白-3(THBS3)对心肌肥大的调节作用。方法 体外人心肌细胞(AC16)经血管紧张素Ⅱ(AngⅡ)处理复制心肌肥大体外模型,随后鬼笔环肽染色观察细胞骨架,Western blotting检测心肌肥大体外模型中胚胎期基因的蛋白表达,以确认模型复制的有效性。实时荧光定量聚合酶链反应检测心肌肥大体外模型中miR-363-5p表达。Western blotting检测肥大心肌细胞中转染miR-363-5p mimics和miR-363-5p inhibitor后,肥大相关表型的变化。双荧光素酶报告基因实验验证miR-363-5p与THBS3的3’-UTR结合作用。设计挽救实验,同时过表达THBS3与miR-363-5p,以评估THBS3是否介导miR-363-5p对心肌肥大的调控。结果 AngⅡ组细胞面积较对照组大(P <0.05),心房钠尿肽(ANP)、B型钠尿肽(BNP)、肌球蛋白β重链(β-MHC)及miR-363-5p较对照组高(P <0.05)。miR-363-5p mimics组miR-363-5p相对表达量较mimics-NC组高(P <0.05),miR-363-5p inhibitor组相对表达量较inhibitor-NC组低(P <0.05);miR-363-5p mimics组ANP、BNP、β-MHC相对表达量较mimics-NC组低(P <0.05),miR-363-5p inhibitor组相对表达量较inhibitor-NC组高(P <0.05)。miR-363-5p mimics组细胞面积较mimics-NC组小(P <0.05),miR-363-5p inhibitor组较inhibitor-NC组大(P <0.05)。miR-363-5p mimics+THBS3-WT组THBS3-WT荧光素酶活性较mimics-NC+THBS3-WT组低。mimics-NC+THBS3-MUT组与miR-363-5p mimics+THBS3-MUT组THBS3-MUT荧光素酶活性比较,差异无统计学意义(P>0.05)。miR-363-5p mimics组THBS3 mRNA和蛋白相对表达量较mimics-NC组低(P <0.05)。THBS3-OE组THBS3 mRNA和蛋白相对表达量较对照组、OE-NC组高(P <0.05)。THBS3-OE+miR-363-5p mimics组细胞面积较OE-NC+miR-363-5p mimics组大(P <0.05)。THBS3-OE+miR-363-5p mimics组ANP、BNP及β-MHC相对表达量较OE-NC+miR-363-5p mimics组高(P <0.05)。结论 过表达miR-363-5p可抑制AngⅡ对AC16细胞的促肥大作用,其机制与减少THBS3表达有关。 展开更多
关键词 心肌细胞肥大 microrna-363-5p 血小板反应蛋白-3
下载PDF
Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease
4
作者 Lu-Lu Han Sheng-Hai Wang +1 位作者 Ming-Yan Yao Hong Zhou 《World Journal of Diabetes》 SCIE 2024年第1期92-104,共13页
BACKGROUND Diabetic kidney disease(DKD),characterized by increased urinary microalbumin levels and decreased renal function,is the primary cause of end-stage renal di-sease.Its pathological mechanisms are complicated ... BACKGROUND Diabetic kidney disease(DKD),characterized by increased urinary microalbumin levels and decreased renal function,is the primary cause of end-stage renal di-sease.Its pathological mechanisms are complicated and multifactorial;Therefore,sensitive and specific biomarkers are needed.Urinary exosome originate from diverse renal cells in nephron segments and partially mirror the pathological changes in the kidney.The microRNAs(miRNAs)in urinary exosome are remark-ably stable and highly tissue-specific for the kidney.METHODS Type 2 diabetic mellitus(T2DM)patients were recruited from the Second Hospital of Hebei Medical University and were divided into two groups:DM,diabetic pa-tients without albuminuria[urinary albumin to creatinine ratio(UACR)<30 mg/g]and DKD,diabetic patients with albuminuria(UACR≥30 mg/g).Healthy subjects were the normal control(NC)group.Urinary exosomal miR-145-5p,miR-27a-3p,and miR-29c-3p,were detected using real-time quantitative polymerase chain reaction.The correlation between exosomal miRNAs and the clinical in-dexes was evaluated.The diagnostic values of exosomal miR-145-5p and miR-27a-3p in DKD were determined using receiver operating characteristic(ROC)analysis.Biological functions of miR-145-5p were investigated by performing RESULTS Urinary exosomal expression of miR-145-5p and miR-27a-3p was more upregulated in the DKD group than in the DM group(miR-145-5p:4.54±1.45 vs 1.95±0.93,P<0.001;miR-27a-3p:2.33±0.79 vs 1.71±0.76,P<0.05)and the NC group(miR-145-5p:4.54±1.45 vs 1.55±0.83,P<0.001;miR-27a-3p:2.33±0.79 vs 1.10±0.51,P<0.001).The exosomal miR-145-5p and miR-27a-3p positively correlated with albuminuria and serum creatinine and negatively correlated with the estimated glomerular filtration rate.miR-27a-3p was also closely related to blood glucose,gly-cosylated hemoglobin A1c,and low-density lipoprotein cholesterol.ROC analysis revealed that miR-145-5p had a better area under the curve of 0.88[95%confidence interval(CI):0.784-0.985,P<0.0001]in diagnosing DKD than miR-27a-3p with 0.71(95%CI:0.547-0.871,P=0.0239).Bioinformatics analysis revealed that the target genes of miR-145-5p were located in the actin filament,cytoskeleton,and extracellular exosome and were involved in the pathological processes of DKD,including apoptosis,inflammation,and fibrosis.CONCLUSION Urinary exosomal miR-145-5p and miR-27a-3p may serve as novel noninvasive diagnostic biomarkers or promising therapeutic targets for DKD. 展开更多
关键词 Urinary exosome microrna-145-5p microrna-27a-3p Diabetic kidney disease Diagnostic biomarkers
下载PDF
Ghrelin regulates insulin resistance by targeting insulin-like growth factor-1 receptor via miR-455-5p in hepatic cells
5
作者 GUO Zhan-hong JU Yue-jun +4 位作者 SHEN Ting ZHANG Lin-qi SHENG Zhong-qi WU Run-ze KONG Ying-hong 《Journal of Hainan Medical University》 CAS 2024年第1期22-28,共7页
Objective: To explore the mechanism by which ghrelin regulates insulin sensitivity through modulation of miR-455-5p in hepatic cells. Methods: HepG2 cells were treated with or without DAG (1 μM). Glucose consumption,... Objective: To explore the mechanism by which ghrelin regulates insulin sensitivity through modulation of miR-455-5p in hepatic cells. Methods: HepG2 cells were treated with or without DAG (1 μM). Glucose consumption, intracellular glycogen content, phosphorylation of PI3K and Akt stimulated by insulin, expression of miR-455-5p, as well as IGF-1R protein level were analyzed. In addition, bioinformatic analysis, dual luciferase reporter assay, miR- 455-5p mimic or inhibitor treatment was conducted to investigate the molecular mechanisms. Results: High glucose treatment upregulated miR-455-5p expression but reduced glucose consumption and glycogen content. DAG reversed the effect of high glucose on glucose metabolism, increased protein level of IGF-1R and phosphorylation of PI3K/Akt stimulated by insulin, as well as downregulated miR-455-5p expression. Bioinformatic analysis indicated IGF-1R was the target of miR-455-5p. Dual luciferase reporter assay, as well as transfection with miR-455-5p mimic/inhibitor confirmed that DAG activated IGF-1R/PI3K/Akt signaling via inhibiting miR-455-5p. Conclusion: DAG improves insulin resistance via miR-455-5p- mediated activation of IGF-1R/PI3K/Akt system, suggesting that suppression of miR-455-5p or activation of DAG may be potential targets for T2DM therapy. 展开更多
关键词 GHRELIN miR-455-5p IGF-1R Insulin resistance HepG2 cells
下载PDF
miR-126-5p通过靶向TRAF3抑制糖氧剥夺再灌注介导的HT22细胞凋亡和炎症
6
作者 赵莉 赵磊 +3 位作者 谢艾伶 王亚梅 吴雨娟 唐爽 《医学分子生物学杂志》 CAS 2024年第1期17-24,共8页
目的探讨miR-126-5p通过靶向肿瘤坏死因子受体相关因子3(tumor necrosis factor receptor-associated factor 3,TRAF3)对糖氧剥夺再灌注(oxygen-glucose deprivation/reperfusion,OGD/R)介导的小鼠海马神经元细胞HT22细胞凋亡和炎症的... 目的探讨miR-126-5p通过靶向肿瘤坏死因子受体相关因子3(tumor necrosis factor receptor-associated factor 3,TRAF3)对糖氧剥夺再灌注(oxygen-glucose deprivation/reperfusion,OGD/R)介导的小鼠海马神经元细胞HT22细胞凋亡和炎症的影响。方法模拟缺血/再灌注损伤(ischemia/reperfusion,I/R)损伤在体外建立氧糖剥夺/复氧(oxygen-glucose deprivation/reperfusion,OGD/R)细胞模型,分析miR-126-5p与TRAF3靶向关系及对HT22细胞凋亡和炎症反应的影响。结果与对照组比较,OGD/R组中miR-126-5p下调而TRAF3 mRNA及蛋白水平上调,细胞存活率及Bcl-2蛋白水平降低,乳酸脱氢酶(lactate dehydrogenase,LDH)释放量、细胞凋亡率、Bax及Cleaved caspase-3蛋白水平升高(P均<0.05)。与OGD/R+mimic-NC组比较,OGD/R+miR-mimic组、OGD+miR-mimic+pcDNA组TRAF3蛋白水平、LDH释放量、细胞凋亡率、Bax及Cleaved caspase-3蛋白水平明显降低,细胞存活率及Bcl-2蛋白水平升高,而OGD+miR-mimic+pcDNA-TRAF3组各指标升高,细胞存活率明显下降(P均<0.05)。结论miR-126-5p通过靶向TRAF3,抑制OGD/R介导的HT22细胞凋亡和炎症反应,从而对神经元细胞发挥保护作用。 展开更多
关键词 microrna-126-5p 糖氧剥夺再灌注 肿瘤坏死因子受体相关因子3 细胞凋亡 炎症 神经元
下载PDF
血清microRNA-186-5p、microRNA-328-5p表达和乳腺癌患者临床病理特征与新辅助化疗效果的关系 被引量:4
7
作者 莫丹 陈喜裕 +1 位作者 何婕 李新宁 《中国现代医学杂志》 CAS 北大核心 2023年第5期9-15,共7页
目的探讨血清microRNA-186-5p(miR-186-5p)、microRNA-328-5p(miR-328-5p)表达和乳腺癌患者临床病理特征与新辅助化疗效果的关系。方法选取2019年2月—2022年2月广西壮族自治区妇幼保健院收治的乳腺癌患者105例作为乳腺癌组,另随机选取... 目的探讨血清microRNA-186-5p(miR-186-5p)、microRNA-328-5p(miR-328-5p)表达和乳腺癌患者临床病理特征与新辅助化疗效果的关系。方法选取2019年2月—2022年2月广西壮族自治区妇幼保健院收治的乳腺癌患者105例作为乳腺癌组,另随机选取该院与乳腺癌患者年龄相匹配的57例健康体检女性作为对照组。乳腺癌患者均接受新辅助化疗,根据化疗反应分为耐药组(30例)和敏感组(75例)。qRT-PCR检测血清miR-186-5p、miR-328-5p表达,比较不同临床病理特征乳腺癌患者血清miR-186-5p、miR-328-5p表达的差异,比较耐药组和敏感组血清miR-186-5p、miR-328-5p表达的差异。多因素Logistic逐步回归分析影响乳腺癌患者新辅助化疗效果的因素。绘制受试者工作特征(ROC)曲线,分析miR-186-5p、miR-328-5p预测乳腺癌患者对新辅助化疗效果的价值。结果乳腺癌组血清miR-186-5p、miR-328-5p mRNA相对表达量低于对照组(P<0.05)。T_(3)、T_(4)期、N_(1~3)期、HER2阳性乳腺癌患者血清miR-186-5p、miR-328-5p mRNA相对表达量低于T_(2)期、N_(0)期、HER2阴性乳腺癌患者(P<0.05)。耐药组血清miR-186-5p、miR-328-5p mRNA相对表达量低于敏感组(P<0.05),T_(3)、T_(4)期、N_(1~3)期占比高于敏感组(P<0.05)。N分期[OR=3.497(95%CI:1.737,7.041)]、miR-186-5p[OR=1.680(95%CI:1.169,2.415)]、miR-328-5p[OR=1.519(95%CI:1.134,2.034)]是影响乳腺癌患者新辅助化疗耐药的危险因素(P<0.05)。ROC曲线分析结果显示,miR-186-5p、miR-328-5p及两者联合预测乳腺癌患者新辅助化疗效果的敏感性分别为76.67%(95%CI:0.553,0.856)、70.00%(95%CI:0.510,0.808)、90.00%(95%CI:0.768,0.977),特异性分别为74.67%(95%CI:0.528,0.831)、76.00%(95%CI:0.544,0.840)、90.67%(95%CI:0.776,0.984)。结论乳腺癌患者血清miR-186-5p、miR-328-5p表达下调,可能与乳腺癌患者临床病理特征及化疗耐药有关,均可作为新辅助化疗疗效评估的标志物。 展开更多
关键词 乳腺癌 临床特征 新辅助化疗 microrna-186-5p microrna-328-5p
下载PDF
紫草素调控MicroRNA-382-5p抑制人增生性瘢痕成纤维细胞纤维化 被引量:2
8
作者 唐玉婷 贺茜 +7 位作者 万瑀 王建军 杨安宁 吴凯 焦运 白志刚 姜怡邓 沈江涌 《中国组织工程研究》 CAS 北大核心 2023年第35期5642-5648,共7页
背景:目前已有研究表明紫草素具有治疗增生性瘢痕的潜力,且miRNA参与增生性瘢痕的病理机制调控,猜测紫草素有可能通过影响miRNA调控增生性瘢痕的发生发展。目的:探讨紫草素通过影响MicroRNA-382-5p对人增生性瘢痕成纤维细胞纤维化的作... 背景:目前已有研究表明紫草素具有治疗增生性瘢痕的潜力,且miRNA参与增生性瘢痕的病理机制调控,猜测紫草素有可能通过影响miRNA调控增生性瘢痕的发生发展。目的:探讨紫草素通过影响MicroRNA-382-5p对人增生性瘢痕成纤维细胞纤维化的作用机制。方法:收集宁夏医科大学总医院烧伤整形外科提供的增生性瘢痕组织及瘢痕旁正常皮肤组织(瘢痕旁3 cm以内),并分别分离出人增生性瘢痕成纤维细胞和正常成纤维细胞用于后续实验。苏木精-伊红染色鉴定正常皮肤和增生性瘢痕;免疫荧光鉴定成纤维细胞;采用实时荧光定量PCR从组织水平检测MicroRNA-382-5p相对表达水平。将增生性瘢痕成纤维细胞随机分为紫草素组(紫草素溶于二甲基亚砜配成浓度为13.46μmol/L的药物干预细胞24 h)、二甲基亚砜组、MicroRNA-382-5p阴性对照组、MicroRNA-382-5p抑制组、紫草素+MicroRNA-382-5p阴性对照组及紫草素+MicroRNA-382-5p过表达组。实时荧光定量PCR检测Ⅰ型胶原蛋白α1、Ⅲ型胶原蛋白α1和α-平滑肌肌动蛋白mRNA表达;Western blot检测Ⅰ型胶原蛋白α1、Ⅲ型胶原蛋白α1和α-平滑肌肌动蛋白的蛋白表达;CCK-8法检测细胞活性;划痕实验检测细胞迁移能力。结果与结论:①与正常皮肤成纤维细胞相比,增生性瘢痕成纤维细胞增殖活性更强(P<0.01);②与二甲基亚砜组相比,紫草素组可以下调增生性瘢痕成纤维细胞中Ⅰ型胶原蛋白α1、Ⅲ型胶原蛋白α1和α-平滑肌肌动蛋白的表达水平(mRNA:P<0.01,蛋白:P<0.01),并抑制增生性瘢痕成纤维细胞迁移(P<0.05);③与正常皮肤相比,MicroRNA-382-5p在增生性瘢痕中呈高表达(P<0.01),且紫草素能下调增生性瘢痕成纤维细胞中MicroRNA-382-5p的表达(P<0.01);④敲低MicroRNA-382-5p能下调增生性瘢痕成纤维细胞中Ⅰ型胶原蛋白α1、Ⅲ型胶原蛋白α1和α-平滑肌肌动蛋白的表达水平(mRNA:P<0.01,蛋白:P<0.01),并抑制增生性瘢痕成纤维细胞迁移(P<0.05);⑤过表达MicroRNA-382-5p能上调在紫草素影响下增生性瘢痕成纤维细胞中Ⅰ型胶原蛋白α1、Ⅲ型胶原蛋白α1和α-平滑肌肌动蛋白的表达水平(mRNA:P<0.01,蛋白:P<0.01),并促进增生性瘢痕成纤维细胞迁移(P<0.01);⑥提示紫草素可通过下调MicroRNA-382-5p的表达抑制增生性瘢痕成纤维细胞的纤维化和迁移。 展开更多
关键词 紫草素 microrna-382-5p 增生性瘢痕 正常皮肤 成纤维细胞 胶原沉积 细胞迁移
下载PDF
MiRNA-145-5p inhibits gastric cancer progression via the serpin family E member 1-extracellular signal-regulated kinase-1/2 axis
9
作者 Hong-Xia Bai Xue-Mei Qiu +1 位作者 Chun-Hong Xu Jian-Qiang Guo 《World Journal of Gastrointestinal Oncology》 SCIE 2024年第5期2123-2140,共18页
BACKGROUND MicroRNAs(miRNAs)regulate gene expression and play a critical role in cancer physiology.However,there is still a limited understanding of the function and regulatory mechanism of miRNAs in gastric cancer(GC... BACKGROUND MicroRNAs(miRNAs)regulate gene expression and play a critical role in cancer physiology.However,there is still a limited understanding of the function and regulatory mechanism of miRNAs in gastric cancer(GC).AIM To investigate the role and molecular mechanism of miRNA-145-5p(miR145-5p)in the progression of GC.METHODS Real-time polymerase chain reaction(RT-PCR)was used to detect miRNA expression in human GC tissues and cells.The ability of cancer cells to migrate and invade was assessed using wound-healing and transwell assays,respectively.Cell proliferation was measured using cell counting kit-8 and colony formation assays,and apoptosis was evaluated using flow cytometry.Expression of the epithelial-mesenchymal transition(EMT)-associated protein was determined by Western blot.Targets of miR-145-5p were predicated using bioinformatics analysis and verified using a dual-luciferase reporter system.Serpin family E member 1(SERPINE1)expression in GC tissues and cells was evaluated using RT-PCR and immunohistochemical staining.The correlation between SERPINE1 expression and overall patient survival was determined using Kaplan-Meier plot analysis.The association between SERPINE1 and GC progression was also tested.A rescue experiment of SERPINE1 overexpression was conducted to verify the relationship between this protein and miR-145-5p.The mechanism by which miR-145-5p influences GC progression was further explored by assessing tumor formation in nude mice.RESULTS GC tissues and cells had reduced miR-145-5p expression and SERPINE1 was identified as a direct target of this miRNA.Overexpression of miR-145-5p was associated with decreased GC cell proliferation,invasion,migration,and EMT,and these effects were reversed by forcing SERPINE1 expression.Kaplan-Meier plot analysis revealed that patients with higher SERPINE1 expression had a shorter survival rate than those with lower SERPINE1 expression.Nude mouse tumorigenesis experiments confirmed that miR-145-5p targets SERPINE1 to regulate extracellular signal-regulated kinase-1/2(ERK1/2).CONCLUSION This study found that miR-145-5p inhibits tumor progression and is expressed in lower amounts in patients with GC.MiR-145-5p was found to affect GC cell proliferation,migration,and invasion by negatively regulating SERPINE1 levels and controlling the ERK1/2 pathway. 展开更多
关键词 Gastric cancer microrna-145-5p Serpin family E member 1 Epithelial-mesenchymal transition proliferation Extracellular signal-regulated kinase-1/2
下载PDF
Exercise-induced modulation of miR-149-5p and MMP9 in LPS-triggered diabetic myoblast ER stress: licorice glycoside E as a potential therapeutic target
10
作者 Yi Du Hong Liu 《Traditional Medicine Research》 2024年第8期23-34,共12页
Background:This study explores the relationship between endoplasmic reticulum(ER)stress and diabetes,particularly focusing on the impact of physical exercise on ER stress mechanisms and identifying potential therapeut... Background:This study explores the relationship between endoplasmic reticulum(ER)stress and diabetes,particularly focusing on the impact of physical exercise on ER stress mechanisms and identifying potential therapeutic drugs and targets for diabetes-related sepsis.The research also incorporates traditional physical therapy perspectives,emphasizing the genomic insights gained from exercise therapy in disease management and prevention.Methods:Gene analysis was conducted on the GSE168796 and GSE94717 datasets to identify ER stress-related genes.Gene interactions and immune cell correlations were mapped using GeneCard and STRING databases.A screening of 2,456 compounds from the TCMSP database was performed to identify potential therapeutic agents,with a focus on their docking potential.Techniques such as luciferase reporter gene assay and RNA interference were used to examine the interactions between microRNA-149-5p and MMP9.Results:The study identified 2,006 differentially expressed genes and 616 miRNAs.Key genes like MMP9,TNF-α,and IL1B were linked to an immunosuppressive state.Licorice glycoside E demonstrated high affinity for MMP9,suggesting its potential effectiveness in treating diabetes.The constructed miRNA network highlighted the regulatory roles of MMP9,IL1B,IFNG,and TNF-α.Experimental evidence confirmed the binding of microRNA-149-5p to MMP9,impacting apoptosis in diabetic cells.Conclusion:The findings highlight the regulatory role of microRNA-149-5p in managing MMP9,a crucial gene in diabetes pathophysiology.Licorice glycoside E emerges as a promising treatment option for diabetes,especially targeting MMP9 affected by ER stress.The study also underscores the significance of physical exercise in modulating ER stress pathways in diabetes management,bridging traditional physical therapy and modern scientific understanding.Our study has limitations.It focuses on the microRNA-149-5p-MMP9 network in sepsis,using cell-based methods without animal or clinical trials.Despite strong in vitro findings,in vivo studies are needed to confirm licorice glycoside E’s therapeutic potential and understand the microRNA-149-5p-MMP9 dynamics in real conditions. 展开更多
关键词 ER stress diabetes physical exercise gene expression microrna-149-5p MMp9 licorice glycoside E traditional physical therapy genomics insights
下载PDF
妊娠糖尿病患者血清microRNA-873-5p、ZEB1与胰岛素抵抗、母婴结局的相关性研究 被引量:1
11
作者 刘莹莹 赵一梅 +1 位作者 杨夫艳 李清桃 《中国现代医学杂志》 CAS 北大核心 2023年第11期14-19,共6页
目的探究妊娠糖尿病(GDM)患者血清microRNA-873-5p(miR-873-5p)、E盒结合锌指蛋白1(ZEB1)与胰岛素抵抗、母婴结局的相关性。方法选取连云港市第一人民医院2021年1月—2022年6月收治的137例GDM患者为研究组,另选取同期该院体检且一般资... 目的探究妊娠糖尿病(GDM)患者血清microRNA-873-5p(miR-873-5p)、E盒结合锌指蛋白1(ZEB1)与胰岛素抵抗、母婴结局的相关性。方法选取连云港市第一人民医院2021年1月—2022年6月收治的137例GDM患者为研究组,另选取同期该院体检且一般资料与研究组患者相匹配的137例健康孕妇为对照组。实时荧光定量聚合酶链反应(q RT-PCR)检测两组研究对象血清miR-873-5p、ZEB1的表达;Pearson法分析GDM患者血清miR-873-5p、ZEB1与胰岛素抵抗指数(HOMA-IR)的相关性;多因素一般Logistic回归分析影响GDM患者母婴结局的相关因素;绘制受试者工作特征(ROC)曲线分析miR-873-5p、ZEB1对GDM患者母婴不良结局的预测效能。结果研究组患者的空腹血糖(FPG)、空腹胰岛素(FINS)及HOMA-IR均高于对照组(P<0.05);研究组患者血清miR-873-5p、ZEB1水平均高于对照组(P<0.05);Pearson法分析结果显示,GDM患者血清miR-873-5p表达(r=0.754,P=0.000)、ZEB1表达(r=0.771,P=0.000)与HOMA-IR均呈正相关;母婴不良结局组的GDM患者血清miR-873-5p、ZEB1表达均高于良好结局组(P<0.05);FPG[OR=1.366(95%CI:1.065,1.752)]、FINS[OR=1.619(95%CI:1.214,2.160)]、HOMA-IR[OR=1.550(95%CI:1.146,2.096)]、miR-873-5p[OR=1.772(95%CI:1.250,2.512)]及ZEB1[OR=1.512(95%CI:1.050,2.177)]均为GDM患者发生母婴不良结局的危险因素(P<0.05);血清miR-873-5p、ZEB1及两者联合预测GDM患者发生母婴不良结局的敏感性分别为71.11%(95%CI:0.670,0.821)、66.67%(95%CI:0.620,0.715)和65.89%(95%CI:0.617,0.727),特异性分别为70.65%(95%CI:0.670,0.821)、85.87%(95%CI:0.775,0.897)和88.04%(95%CI:0.785,0.910),两者联合检测对GDM患者的母婴结局具有较高的特异性。结论GDM患者血清miR-873-5p、ZEB1表达与胰岛素抵抗密切相关,并且两者联合检测对GDM患者的母婴结局具有较好的预测效能。 展开更多
关键词 妊娠糖尿病 microrna-873-5p E盒结合锌指蛋白1 胰岛素抵抗 母婴结局
下载PDF
麻防犀角地黄汤通过调控microRNA-491-5p影响PI3K/Akt/mTOR通路治疗银屑病的机制 被引量:1
12
作者 刘爱民 张步鑫 +6 位作者 赵巍 王丽 孟威威 吴盘红 徐胜东 李伟玲 陆玲玲 《中华中医药学刊》 CAS 北大核心 2023年第5期10-13,I0013,I0014,共6页
目的 观察麻防犀角地黄汤对银屑病小鼠模型的影响,探讨麻防犀角地黄汤治疗银屑病的作用机制。方法 构建咪喹莫特银屑病小鼠模型,灌胃给药麻防犀角地黄汤,观察模型外观及组织病理学改变,Real time PCR检测皮损组织中microRNA-491-5p、PI3... 目的 观察麻防犀角地黄汤对银屑病小鼠模型的影响,探讨麻防犀角地黄汤治疗银屑病的作用机制。方法 构建咪喹莫特银屑病小鼠模型,灌胃给药麻防犀角地黄汤,观察模型外观及组织病理学改变,Real time PCR检测皮损组织中microRNA-491-5p、PI3K、Akt、mTOR mRNA的表达,Western blot检测皮损组织中PI3K、p-PI3K、Akt、p-Akt、mTOR、p-mTOR蛋白的表达。结果 麻防犀角地黄汤能改善小鼠皮损、PASI评分、耳廓外缘厚度、组织病理、体质量等指标,上调microRNA-491-5p mRNA的表达,下调PI3K、Akt、mTOR mRNA的表达量,抑制p-PI3K、p-Akt、p-mTOR的蛋白表达,并表现出部分量效相关性。结论 麻防犀角地黄汤可能通过调控microRNA-491-5p影响PI3K/Akt/mTOR信号通路在银屑病的治疗中发挥作用。 展开更多
关键词 麻防犀角地黄汤 microrna-491-5p pI3K/AKT/MTOR 银屑病
下载PDF
MicroRNA-129-5p、SOX4在宫颈癌组织中的表达及其与患者临床病理特征、预后的关系 被引量:2
13
作者 杨萌 袁超燕 熊焱强 《中国现代医学杂志》 CAS 北大核心 2023年第3期26-31,共6页
目的 探讨宫颈癌组织中micro RNA-129-5p(mi R-129-5p)、性别决定区Y框蛋白4(SOX4)表达与临床病理特征及预后的关系。方法 选取2017年6月-2019年8月湖北民族大学附属民大医院101例宫颈癌患者的宫颈癌组织、癌旁组织标本及其临床资料,根... 目的 探讨宫颈癌组织中micro RNA-129-5p(mi R-129-5p)、性别决定区Y框蛋白4(SOX4)表达与临床病理特征及预后的关系。方法 选取2017年6月-2019年8月湖北民族大学附属民大医院101例宫颈癌患者的宫颈癌组织、癌旁组织标本及其临床资料,根据患者生存情况将其分为生存组79例和死亡组22例。采用免疫组织化学法检测SOX4蛋白阳性表达,采用实时荧光定量聚合酶链反应(q RT-PCR)检测mi R-129-5p m RNA相对表达量。绘制Kaplan-Meier曲线分析mi R-129-5p、SOX4表达与宫颈癌患者3年生存率的关系;采用多因素Cox回归分析宫颈癌患者预后的影响因素。结果 宫颈癌组织mi R-129-5p m RNA相对表达量低于癌旁组织(P<0.05),SOX4蛋白阳性表达率高于癌旁组织(P<0.05)。FIGO分期Ⅱ期、低分化、有淋巴结转移的宫颈癌患者组织中mi R-129-5p高表达、SOX4蛋白阳性表达率高于FIGO分期Ⅰ期、中/高分化、无淋巴结转移患者(P<0.05)。mi R-129-5p低表达患者3年生存率低于mi R-129-5p高表达患者(P<0.05);SOX4蛋白阳性表达患者3年生存率低于SOX4蛋白阴性表达患者(P<0.05)。死亡组FIGO分期Ⅱ期患者比例高于生存组(P<0.05)。SOX4蛋白阳性表达[■=2.793(95%CI:1.495,5.219)]是宫颈癌患者3年内死亡的危险因素,mi R-129-5p高表达[■=0.809(95%CI:0.700,0.935)]是宫颈癌患者3年内死亡的保护因素(P<0.05)。结论 宫颈癌组织中mi R-129-5p表达降低、SOX4表达升高,两者表达与FIGO分期、分化程度、淋巴结转移及3年预后有关,有可作为预后评估的生物标志物。 展开更多
关键词 宫颈癌 microrna-129-5p 性别决定区Y框蛋白4 临床病理特征 预后
下载PDF
MicroRNA-122-5P通过靶向MMP-9抑制TPA诱导的SW480细胞侵袭迁移能力
14
作者 张丽君 石皓 +3 位作者 姜卓言 谢海娟 王林 俞红女 《河北医学》 CAS 2023年第1期86-91,共6页
目的:研究miR-122-5p对TPA诱导人结直肠癌SW480细胞MMP-9表达及侵袭迁移的影响。方法:利用生物信息学筛选结直肠癌差异基因,预测其靶基因miRNA。用TPA(100nM)处理SW480细胞,通过RT-qPCR、Western blot法检测基因和蛋白表达水平;明胶酶... 目的:研究miR-122-5p对TPA诱导人结直肠癌SW480细胞MMP-9表达及侵袭迁移的影响。方法:利用生物信息学筛选结直肠癌差异基因,预测其靶基因miRNA。用TPA(100nM)处理SW480细胞,通过RT-qPCR、Western blot法检测基因和蛋白表达水平;明胶酶谱法检测MMP-9细胞外分泌情况;Transwell检测细胞侵袭和迁移能力。结果:MMP-9在结肠癌组织中高表达,筛选出上游靶基因miR-122-5P;TPA诱导MMP-9 mRNA表达呈时间依赖性上调(P<0.01),诱导miR-122-5p的表达下调(P<0.01);过表达miR-122-5p明显下调TPA诱导的MMP-9 mRNA和蛋白表达(P<0.05),且MMP-9胞外分泌减少,细胞的侵袭、迁移能力显著下降(P<0.01)。结论:miR-122-5p可能通过调控TPA诱导MMP-9的表达,进而抑制结直肠癌SW480细胞侵袭和迁移能力,为克服结直肠癌转移研究提供新的思路。 展开更多
关键词 结直肠癌 microrna-122-5p 基质金属蛋白酶-9 TpA 侵袭
下载PDF
MicroRNA-766-5p靶向SCAI对宫颈癌细胞增殖、周期和凋亡的作用
15
作者 刘倩男 刘伟伟 +2 位作者 毕利红 孙红 张凯 《实用妇科内分泌电子杂志》 2023年第24期1-3,共3页
目的研究MicroRNA-766-5p靶向肿瘤细胞侵袭抑制因子(SCAI)对宫颈癌细胞增殖、周期和凋亡的作用。方法选取人宫颈癌MCF-7细胞模型;CCK8检测细胞增殖;流式细胞术分析细胞周期;Western blot检测细胞周期和凋亡相关蛋白表达。结果MicroRNA-7... 目的研究MicroRNA-766-5p靶向肿瘤细胞侵袭抑制因子(SCAI)对宫颈癌细胞增殖、周期和凋亡的作用。方法选取人宫颈癌MCF-7细胞模型;CCK8检测细胞增殖;流式细胞术分析细胞周期;Western blot检测细胞周期和凋亡相关蛋白表达。结果MicroRNA-766-5p靶向SCAI高效抑制人宫颈癌MCF-7细胞增殖,48 h处理的IC50为(49.33±7.02)nmol/L。低、高药物浓度实验组减少B细胞特性莫洛尼鼠白血病病毒插入位点1(BMI-1)和细胞周期素D1(CyclinD1)、细胞周期蛋白D1(CyclinD1),增加细胞周期素B1(CyclinB1)和P21,G2/M期周期阻滞,促进促凋亡蛋白[Bcl-2相关X蛋白(Bax)、裂解型多聚ADP-核糖聚合酶(c-PARP)]和抑制凋亡蛋白Bcl-2表达。结论MicroRNA-766-5p靶向SCAI能抑制宫颈癌细胞增殖,促进细胞周期阻滞和凋亡。 展开更多
关键词 microrna-766-5p 肿瘤细胞侵袭抑制因子 宫颈癌 细胞增殖 细胞周期 凋亡
下载PDF
MicroRNA-409-5p Inhibits GIST Tumorigenesis and Improves Imatinib Resistance by Targeting KDM4D Expression
16
作者 Cheng QIU Yong-dong FENG Xi YANG 《Current Medical Science》 SCIE CAS 2023年第5期935-946,共12页
Objective Gastrointestinal stromal tumors(GISTs)can rapidly proliferate through angiogenesis.Previous studies indicated the potential influence of microRNA on the progression of tumor immature angiogenesis.This study ... Objective Gastrointestinal stromal tumors(GISTs)can rapidly proliferate through angiogenesis.Previous studies indicated the potential influence of microRNA on the progression of tumor immature angiogenesis.This study aimed to explore the specific mechanism by which microRNA-409-5p(miR-409-5p)contributes to GIST.Methods To identify genes potentially involved in the development and progression of GIST,the differences of miR-409-5p between tumors and adjacent tissues were first analyzed.Following this analysis,target genes were predicted.To further investigate the function of miRNA in GIST cells,two GIST cell lines(GIST-T1 and GIST882)were transfected with lentiviruses that stably expressed miR-409-5p and scrambled miRNA(negative control).Later,the cells were subjected to Western blotting and ELSA to determine any differences in angiogenesis-related genes.Results In GISTs,there was a decrease in the expression levels of miR-409-5p compared to the adjacent tissues.It was observed that the upregulation of miR-409-5p in GIST cell lines effectively inhibited the proteins hypoxia-inducible transcription factor 1β(HIF1β)and vascular endothelial growth factor A(VEGF-A).Further investigations revealed that miR-409-5p acted as an inhibitor of angiogenesis by binding to the 3′-UTR of Lysine-specific demethylase 4D(KDM4D)mRNA.Moreover,the combination of miR-409-5p with imatinib enhanced its inhibitory effect on angiogenesis.Conclusion This study demonstrated that the miRNA-409-5p/KDM4D/HIF1β/VEGF-A signaling pathway could serve as a novel target for the development of therapeutic strategies for the treatment of imatinib-resistance in GIST patients. 展开更多
关键词 microrna-409-5p KDM4D gastrointestinal stromal tumor
下载PDF
MicroRNA-183-5p在动脉粥样硬化患者中的表达及其临床意义
17
作者 周杰 熊雁 曹中静 《中国现代医学杂志》 CAS 北大核心 2023年第8期1-6,共6页
目的分析microRNA-183-5p(miR-183-5p)在动脉粥样硬化患者中的表达及其临床意义。方法选取2021年1月—2022年8月四川省人民医院收治的经血管造影确诊的103例动脉粥样硬化患者为研究组,选取同期该院年龄相当的90例健康体检者为健康组。... 目的分析microRNA-183-5p(miR-183-5p)在动脉粥样硬化患者中的表达及其临床意义。方法选取2021年1月—2022年8月四川省人民医院收治的经血管造影确诊的103例动脉粥样硬化患者为研究组,选取同期该院年龄相当的90例健康体检者为健康组。采用实时荧光定量聚合酶链反应(qRT-PCR)检测两组患者血清miR-183-5p的表达,绘制受试者工作特征(ROC)曲线,分析miR-183-5p在动脉粥样硬化中的诊断价值。结果研究组血清miR-183-5p mRNA相对表达量高于健康组(P<0.05);研究组中高Gensini积分组患者血清miR-183-5p mRNA相对表达量高于低Gensini积分组(P<0.05);Pearson相关性分析结果显示,miR-183-5p与C反应蛋白、颈动脉内中膜厚度及Gensini积分呈正相关(r=0.664、0.571和0.712,均P<0.05);ROC曲线分析结果显示,miR-183-5p诊断动脉粥样硬化的截断值为2.08,敏感性和特异性分别为87.8%(95%CI:0.832,0.924)和91.6%(95%CI:0.877,0.955)。结论动脉粥样硬化患者血清miR-183-5p高表达,能够辅助区分冠状动脉狭窄程度,可作为动脉粥样硬化临床诊断的重要生物标志物。 展开更多
关键词 动脉粥样硬化 microrna-183-5p 冠状动脉狭窄 GENSINI积分
下载PDF
MicroRNA-7-5p通过mTORC2/SGK-1信号通路负向调控人肺泡上皮细胞钠离子通道
18
作者 秦克 李同林 +1 位作者 宫帅 江美芳 《川北医学院学报》 CAS 2023年第4期440-443,共4页
目的:探讨microRNA-7-5p通过哺乳动物雷帕霉素靶蛋白复合物2(mTORC2)/血清糖皮质激素诱导激酶-1(SGK-1)信号通路负向调控人肺泡上皮细胞钠离子通道(ENaC)的机制。方法:对人类非小细胞肺癌肺泡上皮细胞系A549细胞转染microRNA-7-5p模拟剂... 目的:探讨microRNA-7-5p通过哺乳动物雷帕霉素靶蛋白复合物2(mTORC2)/血清糖皮质激素诱导激酶-1(SGK-1)信号通路负向调控人肺泡上皮细胞钠离子通道(ENaC)的机制。方法:对人类非小细胞肺癌肺泡上皮细胞系A549细胞转染microRNA-7-5p模拟剂,设为microRNA-7-5p组,阴性对照组A549细胞转染与目的基因序列无同源性的不表达microRNA-7-5p的阴性对照剂。雷帕霉素组在A549细胞培养基中加入雷帕霉素。PP242组在A549细胞培养基中加入PP242。空白对照组仅加入lipo fectamineTM 2000试剂。采用RT-qPCR检测各组SGK-1 mRNA;免疫印迹法检测SGK-1蛋白、ENaC蛋白的表达量。比较各组的microRNA-7-5p表达水平、SGK-1 mRNA及蛋白表达量、ENaC蛋白表达量。结果:microRNA-7-5p组的microRNA-7-5p表达水平高于空白对照组、阴性对照组、雷帕霉素组和PP242组,A549细胞转染成功上调microRNA-7-5p表达水平(P<0.05)。microRNA-7-5p组中,SGK-1 mRNA水平、SGK-1及ENaC-α、ENaC-β、ENaC-γ蛋白表达量均低于空白对照组、阴性对照组、雷帕霉素组(P<0.05)。结论:microRNA-7-5p可能通过mTORC2/SGK-1信号通路负向调控ENaC。 展开更多
关键词 microrna-7-5p 上皮细胞钠离子通道 哺乳动物雷帕霉素靶蛋白复合物2 血清糖皮质激素诱导激酶-1
下载PDF
支气管哮喘患儿血清microRNA-532-5p的表达及和IL-6相关性
19
作者 李静 李翔 +1 位作者 徐佳 张诗萌 《锦州医科大学学报》 2023年第1期34-37,48,共5页
目的研究支气管哮喘(bronchial asthma,BA)患儿血清microRNA-532-5p、IL-6的表达,并探讨其相关性。方法选取2020年9月至2021年9月哮喘患儿48例和30名健康儿童作为对照。使用荧光定量PCR检测分析microRNA-532-5p的水平,使用ELISA检测血清... 目的研究支气管哮喘(bronchial asthma,BA)患儿血清microRNA-532-5p、IL-6的表达,并探讨其相关性。方法选取2020年9月至2021年9月哮喘患儿48例和30名健康儿童作为对照。使用荧光定量PCR检测分析microRNA-532-5p的水平,使用ELISA检测血清IL-6的表达。结果microRNA-532-5p在哮喘儿童血清中呈现低表达,与IL-6存在相关性,并与儿童哮喘控制测试(C-ACT)分值存在相关性。结论microRNA-532-5p可能与哮喘发病机理有关,并可能变为哮喘的诊断生物标志物或治疗靶标。 展开更多
关键词 支气管哮喘 microrna-532-5p 儿童哮喘控制测试 IL-6 发病机制
下载PDF
非小细胞肺癌患者瘤组织LncRNA LINC00460、miR-98-5p的水平及临床意义
20
作者 王敏 苗玲 赵之寒 《广东医学》 CAS 2023年第11期1368-1373,共6页
目的 探讨非小细胞肺癌(NSCLC)患者瘤组织长链非编码RNA(lncRNA)LINC00460、microRNA-98-5p(miR-98-5p)表达及临床意义。方法 选取2017年1月至2018年12月57例NSCLC患者病例资料进行回顾性研究。术中留取癌组织和癌旁组织(距肿瘤边缘2 c... 目的 探讨非小细胞肺癌(NSCLC)患者瘤组织长链非编码RNA(lncRNA)LINC00460、microRNA-98-5p(miR-98-5p)表达及临床意义。方法 选取2017年1月至2018年12月57例NSCLC患者病例资料进行回顾性研究。术中留取癌组织和癌旁组织(距肿瘤边缘2 cm),比较癌组织及癌旁组织miR-98-5p、LncRNA LINC00460表达,分析癌组织miR-98-5p、LncRNA LINC00460表达与病理特征的相关性,比较不同预后患者miR-98-5p、LncRNA LINC00460表达,logistic回归分析癌组织miR-98-5p、LncRNA LINC00460表达与预后的关系,并比较癌组织miR-98-5p、LncRNA LINC00460表达不同患者总生存率,列线图分析miR-98-5p、LncRNA LINC00460对患者预后评估价值。结果 癌组织miR-98-5p表达低于癌旁组织,LncRNA LINC00460表达高于癌旁组织(P<0.05)。NSCLC患者癌组织miR-98-5p、LncRNA LINC00460表达与临床分期、分化程度、淋巴结转移有关(P<0.05)。死亡者癌组织miR-98-5p表达较存活者低,LncRNA LINC00460表达较存活者高(P<0.05)。Logistic回归分析显示,癌组织LncRNA LINC00460高表达、miR-98-5p低表达是NSCLC患者预后死亡的独立危险因素(P<0.05)。癌组织LncRNA LINC00460高表达者总生存率低于低表达者,miR-98-5p高表达者总生存率高于低表达者(P<0.05)。构建miR-98-5p、LncRNA LINC00460评估患者预后的列线图预测模型与实际病死风险吻合度较高(χ^(2)=6.902,P=0.547)。结论 NSCLC患者癌组织LncRNA LINC00460异常高表达,miR-98-5p异常低表达,且异常表达程度与患者预后关系密切,可为临床评估预后提供参考。 展开更多
关键词 非小细胞肺癌 长链非编码RNA microrna-98-5p 病理特征 预后
下载PDF
上一页 1 2 6 下一页 到第
使用帮助 返回顶部